ID   UD18_HUMAN              Reviewed;         530 AA.
AC   Q9HAW9; B2R8S3; B8K290; O14928; Q8TEX4; Q8WTQ9; Q8WX85;
DT   11-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=UDP-glucuronosyltransferase 1-8;
DE            Short=UDPGT 1-8;
DE            Short=UGT1*8;
DE            Short=UGT1-08;
DE            Short=UGT1.8;
DE            EC=2.4.1.17;
DE   AltName: Full=UDP-glucuronosyltransferase 1-H;
DE            Short=UGT-1H;
DE            Short=UGT1H;
DE   AltName: Full=UDP-glucuronosyltransferase 1A8;
DE   Flags: Precursor;
GN   Name=UGT1A8; Synonyms=GNT1, UGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANTS ARG-132; ALA-154; GLY-173; ALA-202 AND LEU-212.
RX   PubMed=9535849; DOI=10.1074/jbc.273.15.8719;
RA   Strassburg C.P., Manns M.P., Tukey R.H.;
RT   "Expression of the UDP-glucuronosyltransferase 1A locus in human
RT   colon. Identification and characterization of the novel extrahepatic
RT   UGT1A8.";
RL   J. Biol. Chem. 273:8719-8726(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11434514; DOI=10.1097/00008571-200106000-00011;
RA   Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K.,
RA   Kubota S., Carvalho S., Pennington M.W., Owens I.S., Popescu N.C.;
RT   "Thirteen UDP-glucuronosyltransferase genes are encoded at the human
RT   UGT1 gene complex locus.";
RL   Pharmacogenetics 11:357-368(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS GLY-173 AND
RP   TYR-277.
RC   TISSUE=Colon;
RX   PubMed=12042666; DOI=10.1097/00008571-200206000-00004;
RA   Huang Y.-H., Galijatovic A., Nguyen N., Geske D., Beaton D., Green J.,
RA   Green M., Peters W.H., Tukey R.H.;
RT   "Identification and functional characterization of UDP-
RT   glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3.";
RL   Pharmacogenetics 12:287-297(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-173.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-285, AND VARIANTS ARG-132;
RP   ALA-154; GLY-173; ALA-202 AND LEU-212.
RA   Strassburg C.P., Vogel A., Manns M.P.;
RT   "Identification of genetic polymorphisms within the human extrahepatic
RT   UGT1A8 gene.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Guillemette C., Levesque E., Girard H., Bernard O.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-292 AND ASN-344.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   FUNCTION (ISOFORM 2), ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=18004212; DOI=10.1097/FPC.0b013e3282f1f118;
RA   Girard H., Levesque E., Bellemare J., Journault K., Caillier B.,
RA   Guillemette C.;
RT   "Genetic diversity at the UGT1 locus is amplified by a novel 3'
RT   alternative splicing mechanism leading to nine additional UGT1A
RT   proteins that act as regulators of glucuronidation activity.";
RL   Pharmacogenet. Genomics 17:1077-1089(2007).
RN   [10]
RP   FUNCTION.
RX   PubMed=19545173; DOI=10.1021/mp8002557;
RA   Tang L., Singh R., Liu Z., Hu M.;
RT   "Structure and concentration changes affect characterization of UGT
RT   isoform-specific metabolism of isoflavones.";
RL   Mol. Pharm. 6:1466-1482(2009).
RN   [11]
RP   CATALYTIC ACTIVITY, FUNCTION (ISOFORM 2), AND SUBUNIT.
RX   PubMed=20610558; DOI=10.1124/dmd.110.034835;
RA   Bellemare J., Rouleau M., Girard H., Harvey M., Guillemette C.;
RT   "Alternatively spliced products of the UGT1A gene interact with the
RT   enzymatically active proteins to inhibit glucuronosyltransferase
RT   activity in vitro.";
RL   Drug Metab. Dispos. 38:1785-1789(2010).
RN   [12]
RP   VARIANTS VAL-144; GLY-173; THR-231 AND TYR-277.
RX   PubMed=19204906; DOI=10.1002/humu.20946;
RA   Menard V., Girard H., Harvey M., Perusse L., Guillemette C.;
RT   "Analysis of inherited genetic variations at the UGT1 locus in the
RT   French-Canadian population.";
RL   Hum. Mutat. 30:677-687(2009).
CC   -!- FUNCTION: UDPGT is of major importance in the conjugation and
CC       subsequent elimination of potentially toxic xenobiotics and
CC       endogenous compounds. Isoform 2 lacks transferase activity but
CC       acts as a negative regulator of isoform 1.
CC       {ECO:0000269|PubMed:19545173}.
CC   -!- CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor
CC       beta-D-glucuronoside. {ECO:0000269|PubMed:20610558}.
CC   -!- SUBUNIT: Isoform 1 interacts with isoform 2/i2 suggesting that
CC       oligomerization is involved in negative regulation of transferase
CC       activity by isoform 2. Isoform 1 also interacts with respective i2
CC       isoforms of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A9 and
CC       UGT1A10. {ECO:0000269|PubMed:20610558}.
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=i1;
CC         IsoId=Q9HAW9-1; Sequence=Displayed;
CC       Name=2; Synonyms=i2, UGT1A8s;
CC         IsoId=Q9HAW9-2; Sequence=VSP_053964;
CC   -!- TISSUE SPECIFICITY: Colon specific. Isoform 1 and 2 are expressed
CC       in liver, kidney, colon and small intestine; isoform 2 but not
CC       isoform 1 is expressed in liver (PubMed:18004212).
CC       {ECO:0000269|PubMed:18004212, ECO:0000269|PubMed:9535849}.
CC   -!- MISCELLANEOUS: The gene is part of the UGT1A complex locus which
CC       displays alternative use of promoters, first exons and terminal
CC       exons. The locus is defined by 13 first exons, which are
CC       alternatively spliced to 3 other common exons and 2 alternative
CC       terminal exons 5. From the 27 possible mRNA isoforms, 9 produce
CC       functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7,
CC       1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative
CC       exon 5 (5b) as terminal exon is leading to 9 additional
CC       alternatively spliced products termed isoforms i2 and which lack
CC       transferase activity.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF030310; AAB84259.1; -; mRNA.
DR   EMBL; AF297093; AAG30416.1; -; Genomic_DNA.
DR   EMBL; AF462267; AAL75963.1; -; mRNA.
DR   EMBL; AF462268; AAL75964.1; -; mRNA.
DR   EMBL; AC006985; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC019072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK313488; BAG36270.1; -; mRNA.
DR   EMBL; AF465198; AAL73506.1; -; Genomic_DNA.
DR   EMBL; AF465199; AAL73507.1; -; Genomic_DNA.
DR   EMBL; AF465200; AAL73508.1; -; Genomic_DNA.
DR   EMBL; DQ364251; ABC96775.1; -; mRNA.
DR   CCDS; CCDS33402.1; -. [Q9HAW9-1]
DR   RefSeq; NP_061949.3; NM_019076.4. [Q9HAW9-1]
DR   UniGene; Hs.554822; -.
DR   ProteinModelPortal; Q9HAW9; -.
DR   IntAct; Q9HAW9; 7.
DR   STRING; 9606.ENSP00000362549; -.
DR   BindingDB; Q9HAW9; -.
DR   ChEMBL; CHEMBL1743318; -.
DR   DrugBank; DB00861; Diflunisal.
DR   DrugBank; DB00295; Morphine.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00313; Valproic Acid.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   iPTMnet; Q9HAW9; -.
DR   PhosphoSitePlus; Q9HAW9; -.
DR   BioMuta; UGT1A8; -.
DR   DMDM; 29839637; -.
DR   MaxQB; Q9HAW9; -.
DR   PaxDb; Q9HAW9; -.
DR   PeptideAtlas; Q9HAW9; -.
DR   PRIDE; Q9HAW9; -.
DR   DNASU; 54576; -.
DR   Ensembl; ENST00000373450; ENSP00000362549; ENSG00000242366. [Q9HAW9-1]
DR   GeneID; 54576; -.
DR   KEGG; hsa:54576; -.
DR   UCSC; uc002vup.4; human. [Q9HAW9-1]
DR   CTD; 54576; -.
DR   DisGeNET; 54576; -.
DR   GeneCards; UGT1A8; -.
DR   HGNC; HGNC:12540; UGT1A8.
DR   MIM; 191740; gene.
DR   MIM; 606433; gene.
DR   neXtProt; NX_Q9HAW9; -.
DR   OpenTargets; ENSG00000242366; -.
DR   PharmGKB; PA37183; -.
DR   eggNOG; KOG1192; Eukaryota.
DR   eggNOG; COG1819; LUCA.
DR   GeneTree; ENSGT00760000118949; -.
DR   HOGENOM; HOG000220832; -.
DR   HOVERGEN; HBG004033; -.
DR   InParanoid; Q9HAW9; -.
DR   KO; K00699; -.
DR   OMA; MKERAFC; -.
DR   OrthoDB; EOG091G03YY; -.
DR   PhylomeDB; Q9HAW9; -.
DR   TreeFam; TF315472; -.
DR   BioCyc; MetaCyc:HS10706-MONOMER; -.
DR   BRENDA; 2.4.1.17; 2681.
DR   Reactome; R-HSA-156588; Glucuronidation.
DR   SABIO-RK; Q9HAW9; -.
DR   ChiTaRS; UGT1A8; human.
DR   GeneWiki; UGT1A8; -.
DR   GenomeRNAi; 54576; -.
DR   PRO; PR:Q9HAW9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000241635; -.
DR   ExpressionAtlas; Q9HAW9; baseline and differential.
DR   Genevisible; Q9HAW9; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0005504; F:fatty acid binding; IDA:BHF-UCL.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0001972; F:retinoic acid binding; IC:BHF-UCL.
DR   GO; GO:0005496; F:steroid binding; IDA:BHF-UCL.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL.
DR   GO; GO:0009804; P:coumarin metabolic process; IC:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051552; P:flavone metabolic process; IDA:BHF-UCL.
DR   GO; GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL.
DR   GO; GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB.
DR   GO; GO:0045922; P:negative regulation of fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:1904224; P:negative regulation of glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0045939; P:negative regulation of steroid metabolic process; IC:BHF-UCL.
DR   GO; GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL.
DR   GO; GO:0008202; P:steroid metabolic process; IC:BHF-UCL.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   PANTHER; PTHR11926; PTHR11926; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Glycosyltransferase; Membrane; Microsome; Polymorphism;
KW   Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    530       UDP-glucuronosyltransferase 1-8.
FT                                /FTId=PRO_0000036007.
FT   TRANSMEM    488    504       Helical. {ECO:0000255}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ     432    530       SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLR
FT                                PAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRK
FT                                CLGKKGRVKKAHKSKTH -> RKKQQSGRQM (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053964.
FT   VARIANT      53     53       H -> N (in dbSNP:rs45504099).
FT                                /FTId=VAR_052463.
FT   VARIANT     132    132       K -> R. {ECO:0000269|PubMed:9535849,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015543.
FT   VARIANT     144    144       A -> V (in dbSNP:rs17862841).
FT                                {ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_058585.
FT   VARIANT     154    154       G -> A. {ECO:0000269|PubMed:9535849,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015544.
FT   VARIANT     173    173       A -> G (in allele UGT1A8*2;
FT                                dbSNP:rs1042597).
FT                                {ECO:0000269|PubMed:12042666,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:19204906,
FT                                ECO:0000269|PubMed:9535849,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015545.
FT   VARIANT     173    173       A -> V (in dbSNP:rs1042597).
FT                                /FTId=VAR_061871.
FT   VARIANT     202    202       T -> A. {ECO:0000269|PubMed:9535849,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015546.
FT   VARIANT     212    212       M -> L (in dbSNP:rs1126803).
FT                                {ECO:0000269|PubMed:9535849,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015547.
FT   VARIANT     231    231       A -> T (in dbSNP:rs72551325).
FT                                {ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_058586.
FT   VARIANT     277    277       C -> Y (in allele UGT1A8*3; dramatic
FT                                reduction in catalytic activity;
FT                                dbSNP:rs17863762).
FT                                {ECO:0000269|PubMed:12042666,
FT                                ECO:0000269|PubMed:19204906}.
FT                                /FTId=VAR_015549.
SQ   SEQUENCE   530 AA;  59742 MW;  AD838436940F4190 CRC64;
     MARTGWTSPI PLCVSLLLTC GFAEAGKLLV VPMDGSHWFT MQSVVEKLIL RGHEVVVVMP
     EVSWQLGKSL NCTVKTYSTS YTLEDLDREF MDFADAQWKA QVRSLFSLFL SSSNGFFNLF
     FSHCRSLFND RKLVEYLKES SFDAVFLDPF DACGLIVAKY FSLPSVVFAR GIACHYLEEG
     AQCPAPLSYV PRILLGFSDA MTFKERVRNH IMHLEEHLFC QYFSKNALEI ASEILQTPVT
     AYDLYSHTSI WLLRTDFVLD YPKPVMPNMI FIGGINCHQG KPLPMEFEAY INASGEHGIV
     VFSLGSMVSE IPEKKAMAIA DALGKIPQTV LWRYTGTRPS NLANNTILVK WLPQNDLLGH
     PMTRAFITHA GSHGVYESIC NGVPMVMMPL FGDQMDNAKR METKGAGVTL NVLEMTSEDL
     ENALKAVIND KSYKENIMRL SSLHKDRPVE PLDLAVFWVE FVMRHKGAPH LRPAAHDLTW
     YQYHSLDVIG FLLAVVLTVA FITFKCCAYG YRKCLGKKGR VKKAHKSKTH
//
